These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23883545)

  • 1. Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2013; 20(7):603-15. PubMed ID: 23883545
    [No Abstract]   [Full Text] [Related]  

  • 2. Women. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2014; 21(4):291-5. PubMed ID: 24335044
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(12):835-49. PubMed ID: 24172256
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(12):850-60. PubMed ID: 24335039
    [No Abstract]   [Full Text] [Related]  

  • 5. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.
    Kinoshita M; Yokote K; Arai H; Iida M; Ishigaki Y; Ishibashi S; Umemoto S; Egusa G; Ohmura H; Okamura T; Kihara S; Koba S; Saito I; Shoji T; Daida H; Tsukamoto K; Deguchi J; Dohi S; Dobashi K; Hamaguchi H; Hara M; Hiro T; Biro S; Fujioka Y; Maruyama C; Miyamoto Y; Murakami Y; Yokode M; Yoshida H; Rakugi H; Wakatsuki A; Yamashita S;
    J Atheroscler Thromb; 2018 Sep; 25(9):846-984. PubMed ID: 30135334
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):93-8. PubMed ID: 24335040
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(10):733-42. PubMed ID: 23892529
    [No Abstract]   [Full Text] [Related]  

  • 8. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2013; 20(6):517-23. PubMed ID: 23665881
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):86-92. PubMed ID: 24335038
    [No Abstract]   [Full Text] [Related]  

  • 10. Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):82-5. PubMed ID: 24335037
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis of atherosclerosis. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2014; 21(4):296-8. PubMed ID: 24335045
    [No Abstract]   [Full Text] [Related]  

  • 12. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M
    J Atheroscler Thromb; 2007 Apr; 14(2):45-50. PubMed ID: 17485887
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M
    J Atheroscler Thromb; 2007 Dec; 14(6):267-77. PubMed ID: 18176013
    [No Abstract]   [Full Text] [Related]  

  • 14. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.
    Okamura T; Tsukamoto K; Arai H; Fujioka Y; Ishigaki Y; Koba S; Ohmura H; Shoji T; Yokote K; Yoshida H; Yoshida M; Deguchi J; Dobashi K; Fujiyoshi A; Hamaguchi H; Hara M; Harada-Shiba M; Hirata T; Iida M; Ikeda Y; Ishibashi S; Kanda H; Kihara S; Kitagawa K; Kodama S; Koseki M; Maezawa Y; Masuda D; Miida T; Miyamoto Y; Nishimura R; Node K; Noguchi M; Ohishi M; Saito I; Sawada S; Sone H; Takemoto M; Wakatsuki A; Yanai H
    J Atheroscler Thromb; 2024 Jun; 31(6):641-853. PubMed ID: 38123343
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid Management in a Japanese Community:Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012.
    Tada H; Kawashiri MA; Nohara A; Inazu A; Kobayashi J; Yasuda K; Mabuchi H; Yamagishi M; Hayashi K
    J Atheroscler Thromb; 2017 Mar; 24(3):338-345. PubMed ID: 27568728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M;
    J Atheroscler Thromb; 2007 Aug; 14(4):155-8. PubMed ID: 17827859
    [No Abstract]   [Full Text] [Related]  

  • 17. [Essence of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version and Treatment Guide for Dyslipidemia 2013--Current Strategy for the Lipid Assessment].
    Arai H
    Rinsho Byori; 2014 Sep; 62(9):878-83. PubMed ID: 27526533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target.
    Shimano H; Arai H; Harada-Shiba M; Ueshima H; Ohta T; Yamashita S; Gotoda T; Kiyohara Y; Hayashi T; Kobayashi J; Shimamoto K; Bujo H; Ishibashi S; Shirai K; Oikawa S; Saito Y; Yamada N
    J Atheroscler Thromb; 2008 Jun; 15(3):116-21. PubMed ID: 18603817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present Execution of and Problems with Clinical Lipid Examination and Application of "the Japan Atherosclerotic Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2012"].
    Igarashi M; Tanji Y; Nomura T; Yamaguchi H
    Rinsho Byori; 2014 Sep; 62(9):884-91. PubMed ID: 27526534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment for hypertension with metabolic disorders (DM etc)].
    Shimamoto K; Miura T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():513-9. PubMed ID: 16981585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.